Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion type Assertion NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_head.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion description "[Vitreous samples from diabetic patients with proliferative and non-proliferative diabetic retinopathy (PDR, NPDR), and from non-diabetic patients with macular hole (control group) were selected for IRBP quantitative assessment by proteomic analysis (fluorescence-based difference gel electrophoresis) and western blot.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion evidence source_evidence_literature NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion SIO_000772 19823802 NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion wasDerivedFrom befree-20140225 NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.
- NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_assertion wasGeneratedBy ECO_0000203 NP602371.RAzFCwLNTDKsHkKnZmRxIHfj0_IEliNLhwxqe4DaZ_CEs130_provenance.